India's Wockhardt scales 9-year peak on antibiotic drug approval

Wockhardt

03/01/2025 04:27

** Shares of pharma co Wockhardt  WCKH.NS  rise as much as
9.4% to highest since Dec. 2015 to 1,582.95 rupees
    ** Co on Thursday said Indian drug regulator approved co's
antibiotic drug Miqnaf for treatment of pneumonia
    ** WCKH shares on track for fourth straight week of gains
    ** WCKH shares jumped more than three-fold last year vs 39%
gains in pharma index  .NIPHARM 


 (Reporting by Sethuraman NR in Bengaluru)
 ((Sethuraman.NR@thomsonreuters.com; (+91 9945291420); Reuters
Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net))